SCHEMBL30810232

SCHEMBL30810232

Cc1c(O)c(C(N)=O)cc(Cl)c1-c1nccs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKMYT1 Q99640 1/20 0.37
SMPD3 Q9NY59 1/20 0.37
EEF2K O00418 2/20 0.35
CYP1A1 P04798 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP1B1 Q16678 2/20 0.35
CHEK2 O96017 1/20 0.35
TYK2 P29597 1/20 0.35
SCN9A Q15858 1/20 0.34
NNMT P40261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
LRRK2 Q5S007 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30810277 0.74 CHEK2 (0.40) CYP3A4CYP2C9PKMYT1SMPD3CHEK2
SCHEMBL30174294 0.74 CHEK2 (0.40) CYP3A4CYP2C9PKMYT1SMPD3EEF2K
SCHEMBL2729192 0.74 CHEK2 (0.40) CYP3A4CYP2C9PKMYT1SMPD3EEF2K
SCHEMBL2726309 0.73 CYP3A4 (0.42) CYP3A4CYP2C9PKMYT1EEF2KCHEK2
SCHEMBL3350408 0.73 SMPD3 (0.46) CYP3A4CYP2C9PKMYT1SMPD3CHEK2
SCHEMBL28031696 0.72 SMN1; SMN2 (0.42) CHEK2TYK2MEN1KMT2AKDM4E
SCHEMBL30810193 0.71 HPGD (0.42) CYP3A4CYP2C9PKMYT1EEF2KCHEK2
SCHEMBL30810276 0.69 PARP1 (0.45) EEF2KCYP1A2CHEK2TYK2MEN1
SCHEMBL1932926 0.68 CHEK2 (0.38) CYP3A4CYP2C9PKMYT1SMPD3EEF2K
SCHEMBL28139104 0.68 PDPK1 (0.40) ACLYTYK2THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed